Parkinson’s Foundation Hosts 2022 Care Partner Summits

Events offer care partners guidance on managing Parkinson’s caregiving

MIAMI & NEW YORK (October 11, 2022) — Today, the Parkinson’s Foundation announced a series of five regional events, the 2022 Care Partner Summit. This year, the summit’s primary focus is helping care partners create a plan to best manage unexpected bumps on the unpredictable path of Parkinson’s disease (PD) caregiving.

An estimated one million people in the U.S. live with PD, and approximately 60,000 individuals are newly diagnosed each year. These numbers also reflect the thousands of individuals who become caregivers each year, and the millions of care partners adapting to their changing roles each day.

“The Care Partner Summit offers the unique opportunity for care partners of people with Parkinson’s to come together to consider how their own needs impact their ability to support their loved one and whether their relationship has or needs to evolve as the disease progresses,” said Parkinson’s Foundation Director of Education Annie Brooks.

The Care Partner Summit provides an opportunity to focus on how to manage the evolving roles, identities and thinking changes often associated with PD. The regional events include:

The event is made possible by presenting sponsor, Acadia Pharmaceuticals. For more information about registering for a Care Partner Summit in your region, visit or call the Parkinson’s Foundation Helpline at (800) 4PD-INFO (473-4636) for assistance in English and Spanish.


About the Parkinson’s Foundation
The Parkinson’s Foundation makes life better for people with Parkinson’s disease by improving care and advancing research toward a cure. In everything we do, we build on the energy, experience and passion of our global Parkinson’s community. Since 1957, the Parkinson’s Foundation has invested more than $400 million in Parkinson’s research and clinical care. Connect with us on Parkinson.orgFacebookTwitterInstagram or call (800) 4PD-INFO (473-4636).

About Parkinson’s Disease
Affecting an estimated one million Americans and 10 million worldwide, Parkinson’s disease is the second-most common neurodegenerative disease after Alzheimer’s and is the 14th-leading cause of death in the U.S. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression), as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for Parkinson’s and 60,000 new cases are diagnosed each year in the U.S. alone.

Back to Top